Armata Pharmaceuticals, Inc. (ARMP) › EPS (Diluted)Armata Pharmaceuticals, Inc. (ARMP) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2013: $-0.642014: $-2.332015: $-1.992016: $-24.672017: $-2.182018: $-3.592019: $-2.552020: $-1.352021: $-0.962022: $-1.082023: $-1.912024: $-0.892025: $-4.80$-4.802013EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-4.80-439.3%2024$-0.89+53.4%2023$-1.91-76.9%2022$-1.08-12.5%2021$-0.96+28.9%2020$-1.35+47.1%2019$-2.55+29.0%2018$-3.59-64.7%2017$-2.18+91.2%2016$-24.67-1139.7%2015$-1.99+14.6%2014$-2.33-264.1%2013$-0.64—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share